Vera therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Brisbane, calif., nov. 22, 2024 (globe newswire) -- vera therapeutics, inc. (nasdaq: vera) today announced that on november 18, 2024, the compensation committee of vera's board of directors granted inducement awards consisting of a non-qualified stock option to purchase 108,000 shares of class a common stock and restricted stock units (rsus) for 53,000 shares of class a common stock to jason s. carter, vera's new chief legal officer, under vera's 2024 inducement plan. the compensation committee approved the awards as an inducement material to the new employee's employment in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking